Xintōpica® 3 mg
Antipruritic. Control of Atopic Dermatitis and Pruritus Associated with Allergic Dermatitis in Dogs.
Soft Chews
Each 2000 mg chewable tablet contains: Oclacitinib (as Oclacitinib maleate) 3 mg, Excipients and flavorings q.s.ad 1 tablet.
Treatment of pruritus associated with allergic dermatitis in dogs, including flea allergies. Treatment of the clinical manifestations of atopic dermatitis in dogs. Temporary relief of pruritus associated with sarcoptic mange.
Xintōpica® It is administered orally, at 0.4 - 0.6 mg/kg PO every 12 hours for up to 14 days, then 0.4 - 0.6 mg/kg every 24 hours as maintenance therapy.
SENASA Registry: F.115.031.N.00011.
Petmedica® is a division of Agrovet Market S.A.
Insert
Shared
Whatsapp
This content is an informational reference and should not be considered as
recommendation of use.
